ABCL
Price
$2.06
Change
+$0.03 (+1.48%)
Updated
May 12 closing price
Capitalization
605.92M
91 days until earnings call
ABEO
Price
$5.60
Change
+$0.33 (+6.26%)
Updated
May 12 closing price
Capitalization
257.18M
97 days until earnings call
Ad is loading...

ABCL vs ABEO

Header iconABCL vs ABEO Comparison
Open Charts ABCL vs ABEOBanner chart's image
AbCellera Biologics
Price$2.06
Change+$0.03 (+1.48%)
Volume$4.4M
Capitalization605.92M
Abeona Therapeutics
Price$5.60
Change+$0.33 (+6.26%)
Volume$3.72M
Capitalization257.18M
ABCL vs ABEO Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. ABEO commentary
May 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and ABEO is a Hold.

Ad is loading...
COMPARISON
Comparison
May 13, 2025
Stock price -- (ABCL: $2.06 vs. ABEO: $5.60)
Brand notoriety: ABCL and ABEO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 109% vs. ABEO: 209%
Market capitalization -- ABCL: $605.92M vs. ABEO: $257.18M
ABCL [@Biotechnology] is valued at $605.92M. ABEO’s [@Biotechnology] market capitalization is $257.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileABEO’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ABEO’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABCL and ABEO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while ABEO’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 6 bearish.
  • ABEO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ABEO is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -5.94% price change this week, while ABEO (@Biotechnology) price change was -12.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.48%. For the same industry, the average monthly price growth was +10.12%, and the average quarterly price growth was -9.68%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

ABEO is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (-3.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($606M) has a higher market cap than ABEO($257M). ABEO YTD gains are higher at: 0.539 vs. ABCL (-29.693). ABEO has higher annual earnings (EBITDA): -64.95M vs. ABCL (-211.2M). ABCL has more cash in the bank: 605M vs. ABEO (110M). ABEO has less debt than ABCL: ABEO (23.1M) vs ABCL (67.8M). ABCL has higher revenues than ABEO: ABCL (23.1M) vs ABEO (0).
ABCLABEOABCL / ABEO
Capitalization606M257M236%
EBITDA-211.2M-64.95M325%
Gain YTD-29.6930.539-5,513%
P/E RatioN/AN/A-
Revenue23.1M0-
Total Cash605M110M550%
Total Debt67.8M23.1M294%
FUNDAMENTALS RATINGS
ABEO: Fundamental Ratings
ABEO
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
13

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLABEO
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NOINX15.72N/A
N/A
Northern International Equity Index
CCERX26.05N/A
N/A
Columbia Large Cap Enhanced Core R
VSCOX24.44N/A
N/A
JPMorgan Small Cap Blend A
LIONX9.19N/A
N/A
Issachar N
FTSIX35.12N/A
N/A
FullerThaler Behvrl S-M Cor Eq Instl

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+1.48%
CRSP - ABCL
62%
Loosely correlated
+5.53%
ABSI - ABCL
59%
Loosely correlated
+6.55%
RXRX - ABCL
58%
Loosely correlated
+7.16%
NTLA - ABCL
58%
Loosely correlated
+5.30%
BEAM - ABCL
57%
Loosely correlated
+4.77%
More

ABEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABEO has been loosely correlated with ELVN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ABEO jumps, then ELVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABEO
1D Price
Change %
ABEO100%
+6.26%
ELVN - ABEO
46%
Loosely correlated
+3.20%
RGLS - ABEO
44%
Loosely correlated
N/A
APGE - ABEO
44%
Loosely correlated
+6.14%
ZYME - ABEO
43%
Loosely correlated
+6.32%
ERAS - ABEO
43%
Loosely correlated
N/A
More